BioSpace News Archive

Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases, provides an update on its TACTI-002 and AIPAC studies for its lead product candidate, eftilagimod alpha (“efti” or “IMP321”).

Heska Corporation announced that the Company has acquired a 100% interest in CVM Diagnostico Veterinario, S.L. and CVM Ecografía, S.L. of Spain.

Sebacia, Inc., a privately held commercial stage dermatology and aesthetics company, today provided a business update, first announcing an update to its leadership team.

Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that Will Lewis, Chairman and Chief Executive Officer of Insmed, will present at the 38th Annual J.P. Morgan Healthcare Conference

First subject treated in SYNB1891 immuno-oncology study, data from monotherapy arm expected in 2020

Company Raises $145 Million in Eighteen Months to Complete Development and Early Commercialization of Breakthrough DNA Sequencing Platform

American Brain Tumor Association announced a new partnership with the Uncle Kory Foundation to accelerate brain tumor research.

Co-Diagnostics, Inc. announced that it has been recognized as a company that represents the Nasdaq Biotech Index in leading the nation in solving America’s Healthcare challenges following a year of several Company milestones, and invited to ring the Nasdaq Stock Market opening bell on January 13 in San Francisco, California.

Landos Biopharma announced that Dr. Josep Bassaganya-Riera, Chairman, President, and Chief Executive Officer, will present a company overview at the 38th Annual J.P. Morgan Healthcare Conference.

Contextual Genomics, a leading cancer genomics company, announced that it has named Brady Davis to its executive team.